CN111088236B - Single-stranded RNA peptide ligase sRPoseI and use method thereof - Google Patents

Single-stranded RNA peptide ligase sRPoseI and use method thereof Download PDF

Info

Publication number
CN111088236B
CN111088236B CN202010077332.5A CN202010077332A CN111088236B CN 111088236 B CN111088236 B CN 111088236B CN 202010077332 A CN202010077332 A CN 202010077332A CN 111088236 B CN111088236 B CN 111088236B
Authority
CN
China
Prior art keywords
leu
ligase
ser
arg
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN202010077332.5A
Other languages
Chinese (zh)
Other versions
CN111088236A (en
Inventor
黄志玲
黄种山
其他发明人请求不公开姓名
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huang Zhongshan
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010077332.5A priority Critical patent/CN111088236B/en
Publication of CN111088236A publication Critical patent/CN111088236A/en
Application granted granted Critical
Publication of CN111088236B publication Critical patent/CN111088236B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a novel single-stranded RNA peptide ligase sRPPlaseI which can be used for catalyzing covalent linkage of specific single-stranded RNA and specific polypeptide, and enzymatic properties and a using method thereof. The amino acid sequence of srplatei enzyme is set forth in SEQ ID NO: 2, and the corresponding gene coding sequence is shown as SEQ ID NO: 1 is shown in the specification; the sRPlasII enzyme recognizes a specific RNA single strand whose 5 '-end is initiated with a 5' -AUGAUCCAG-3 'sequence and whose 5' -end ribonucleotide A is in a phosphorylated state and a specific polypeptide chain whose C-end is initiated with a 7-peptide N '-MANCEHL-C', and catalyzes the covalent bonding of the two to each other. The connecting product of the single-stranded RNA and the polypeptide has a characteristic absorption peak at a 351nm wavelength, and can be used for measuring the reactivity of sRPoseI ligase. The sRPlasII ligase buffer was prepared from 500mM Tris-HCl, 100mM Mg at pH 7.52+10mM ATP and 10mM DTT, the temperature range of the optimal reaction is 30-40 ℃, and the connection reaction time is 10-15 min. The novel single-stranded RNA polypeptide ligase provided by the invention can be used as a tool enzyme for genetic engineering and genetic analysis.

Description

Single-stranded RNA peptide ligase sRPPlaseI and use method thereof
Technical Field
The invention relates to the field of molecular biology, in particular to a brand-new ligase capable of connecting specific single-stranded RNA and specific polypeptide and a use method thereof.
Background
The gene engineering field is not independent of various molecular biology tool enzymes, the tool enzymes can realize in vitro nucleic acid amplification, transcription or reverse transcription, digestion or excision, connection and modification, protein digestion or excision and the like, and are widely used in the fields of target gene amplification, nucleic acid sequence analysis, recombinant DNA preparation, vector construction, nucleic acid probe marking, protein analysis and the like, for example, DNA polymerase is a core component in a PCR system, and the construction of a cDNA library is not independent of RNA polymerase. The commonly used tool enzymes for genetic engineering include DNA polymerase, restriction endonuclease, DNA ligase, RNA polymerase, reverse transcriptase, exonuclease, DNA methylase, ribonuclease, deoxyribonuclease, polynucleotide kinase, alkaline phosphatase, terminal nucleotidyl transferase, and various proteases. Most of the current commercial molecular tool enzymes are derived from microorganisms mainly due to the fact that microorganisms grow and proliferate fast and metabolize vigorously, and in addition, expression, separation and purification of the enzymes are facilitated. Microorganisms in nature are diverse in their species, in the micro-ecology they occupy, and thus, in their metabolic forms and processes, which are diverse, and they are not isolated from the corresponding enzymes capable of performing various biochemical reactions, and thus, they are a huge resource pool of molecular enzymes. For example, T4 ligase derived from the T4 bacteriophage, which is originally used by the bacteriophage to repair DNA cleaved by a restriction endonuclease of a host cell, has high ligation efficiency. As more and more enzyme molecules are being explored, the number and use of molecular tools enzymes is increasing, which greatly opens up the field of genetic engineering research and applications.
In the earlier stage of research on microbial ecosystems degraded by dry straw, the applicant finds that a specific single-stranded RNA peptide ligase exists in the system, and can identify a specific sequence at the 5' end of a specific mRNA and covalently connect the specific sequence with a specific polypeptide so as to regulate the process of translating the specific mRNA into protein. Further, by means of bioinformatic design, the applicant has engineered the single-stranded RNA peptide ligase gene to develop 1 specific single-stranded DNA peptide ligase and 2 specific double-stranded DNA peptide ligase, which can recognize a specific DNA single-stranded sequence at the 5 '-end of a specific single-stranded DNA or a specific DNA double-stranded sequence at the 5' -end of a specific double-stranded DNA and covalently link them to a specific polypeptide, respectively. On the basis of exogenous expression of these nucleic acid peptide ligases, the applicants have explored their enzymatic properties and methods of use. There are many commercially available DNA ligases (such as T4 DNAlagase from Saimer fly, USA) and modified enzymes (DNA methylase from NEB), which are only used for linking and specifically modifying nucleic acid fragments, and no ligase which can covalently link nucleic acid fragments and polypeptide fragments is reported. The invention provides a brand-new nucleic acid polypeptide ligase, which can be used as a tool enzyme for genetic engineering and genetic analysis and has huge application prospects in the fields of nucleic acid labeling, nucleic acid analysis and the like.
Disclosure of Invention
The present invention provides novel nucleic acid polypeptide ligases useful for ligating specific nucleic acid fragments to specific polypeptide fragments and methods of using and enzymatic properties thereof.
The technical scheme adopted by the invention for solving the technical problem is as follows:
the object (1) of the present invention is to provide a single-stranded RNA peptide ligase sRPPlaseI which can be used for catalyzing covalent ligation of a specific single-stranded RNA and a specific polypeptide, and its enzymatic properties and methods of use. The amino acid sequence of the sRPlaseI enzyme is set forth in SEQ ID NO: 2, and the corresponding gene coding sequence is shown as SEQ ID NO: 1 is shown in the specification; the sRPoseI enzyme can recognize a specific RNA single chain of which the 5 ' end is initiated by a 5 ' -AUGAUCCAG-3 ' sequence and the 5 ' end ribonucleotide A is in a phosphorylated state and a specific polypeptide chain of which the C end is initiated by a 7-peptide N ' -MANCEHL-C ', and catalyzes a dehydration condensation reaction between the phosphorylated adenine ribonucleotide A at the 5 ' end of the RNA single chain and a leucine L at the C end of the polypeptide chain to form a phosphorus-carbon bond with O = P-C = O structure, so that the single-stranded RNA and the polypeptide are connected with each other by covalent bonds; the RP of the single-stranded RNA and the polypeptide has a maximum absorption peak at a wavelength of 351nm, and the peak is a characteristic absorption peak and can be used for measuring the reactivity of sRPLSeI ligase. The reaction system for sRPlaseI ligase is: (1) 1 ng/mu L-100 ng/mu L of specific RNA single strand; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer consisting of 500mM Tris-HCl, 100mM Mg, pH 7.52+10mM ATP and 10mM DTT, and adding 0.1 mu L ligase buffer solution to each 1 mu L reaction system; (4) 1. mu.g of sRPoseI enzyme; (5) deionized water to make up to the required volume. Wherein the specific RNA single strand refers to an RNA single strand of which the 5 '-end is initiated with a 5' -AUGAUCCAG-3 'sequence and the 5' -end ribonucleotide A is in a phosphorylated state, and the specific polypeptide refers to a polypeptide chain of which the C-end is initiated with a 7-peptide N '-MANCEHL-C'. The optimal reaction temperature range of sRPoseI ligase is 30-40 ℃, the ligation reaction time is 10-15 min, and the reaction system can be kept at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely stopped.
The invention aims at providing a single-stranded DNA peptide ligase sDPlaseI which can be used for catalyzing covalent linkage of specific single-stranded DNA and specific polypeptide, and the enzymological characteristics and the using method thereof. The amino acid sequence of the sDPlaseI enzyme is shown in SEQ ID NO: 4, and the corresponding gene coding sequence is shown as SEQ ID NO: 3 is shown in the figure; the sDPlaseI enzyme can recognize a specific DNA single chain of which the 5 ' end is initially provided with a 5 ' -ATGATCCAG-3 ' sequence and the 5 ' end deoxyribonucleotide A is in a phosphorylation state and a specific polypeptide chain of which the C end is initially provided with a 7 peptide N ' -MANCEHL-C ', and catalyze the dehydration condensation reaction between the phosphorylated adenine deoxyribonucleotide A at the 5 ' end of the DNA single chain and the leucine L at the C end of the polypeptide chain to form a phosphorus-carbon bond with O = P-C = O structure, so that the single-chain DNA and the polypeptide are connected with each other by covalent bonds; the single-stranded DNA and polypeptide ligation product sDP has a maximum absorption peak at 358nm, which is a characteristic absorption peak and can be used for the determination of sDPlaseI ligase reaction activity. The reaction system for the sDPlaseI ligase is as follows: (1) 1 ng/. mu.L-100 ng/. mu.L of a specific DNA single strand; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer consisting of 500mM Tris-HCl, 100mM Mg, pH 7.52+10mM ATP and 10mM DTT, and adding 0.1 mu L ligase buffer solution to each 1 mu L reaction system; (4) 1 μ g of sDPlaseI enzyme; (5) and (5) adding deionized water to the required volume. Wherein the specific DNA single strand is a DNA single strand having 5 '-end starting with 5' -ATGATCCAG-3 'sequence and 5' -end deoxyribonucleotide A in phosphorylated state, and the specific polypeptide is a polypeptide chain having C-end starting with 7 peptides N '-MANCEHL-C'. The optimal reaction temperature range of the sDPlaseI ligase is 30-40 ℃, the ligation reaction time is 5-15 min, and the reaction system can be kept at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely stopped.
The invention aims at providing a double-stranded DNA peptide ligase dDPlaseI which can be used for catalyzing covalent linkage of specific double-stranded DNA and specific polypeptide, and the enzymatic properties and the using method thereof. The amino acid sequence of dplasei enzyme is shown in SEQ ID NO: 6, the corresponding gene coding sequence is shown as SEQ ID NO: 5 is shown in the specification; the dDPlaseI enzyme can recognize a double-stranded sequence with 5 '-ATGATCCAG-3' starting from the 5 'end and the 5' endThe method comprises the following steps of (1) catalyzing a dehydration condensation reaction between a specific DNA double-chain with a phosphorylated terminal deoxyribonucleotide A and a specific polypeptide chain with a C-terminal starting from 7 peptides of N ' -MANCEHL-C ', and catalyzing adenine deoxyribonucleotide A phosphorylated at the 5 ' -terminal of the DNA double-chain and leucine L at the C-terminal of the polypeptide chain to form a phosphorus-carbon bond with an O = P-C = O structure, so that the double-chain DNA and the polypeptide are connected with each other by a covalent bond; the double-stranded DNA and polypeptide ligation product dDPI has a maximum absorption peak at the wavelength of 360nm, and the peak is a characteristic absorption peak and can be used for measuring the reaction activity of dDPlaseI ligase. The reaction system for dplastei ligase was: (1) 1 ng/. mu.L-100 ng/. mu.L of a specific DNA duplex; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer, prepared from 450mM Tris-HCl, 100mM Mg, pH 7.82+80mM NaCl, 20mM MATP and 8mM Triton X-100, and adding 0.1 mu L of ligase buffer solution into each 1 mu L of reaction system; (4) 1 μ g of dplastei enzyme; (5) and (5) adding deionized water to the required volume. Wherein the specific DNA double strand is a DNA double strand of which 5 '-end is initially a 5' -ATGATCCAG-3 'double strand sequence and of which 5' -end deoxyribonucleotide A is in a phosphorylated state, and the specific polypeptide is a polypeptide chain of which C-end is initiated by the 7 peptide N '-MANCEHL-C'. The optimal reaction temperature range of dDPlaseI ligase is 35-45 ℃, the ligation reaction time is 3-10 min, and the reaction system can be kept at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely stopped.
Object (4) of the present invention is to provide another double-stranded DNA peptide ligase dplastii which can be used to catalyze the covalent ligation of specific double-stranded DNA and specific polypeptides, as well as its enzymatic properties and methods of use. The amino acid sequence of dplastei enzyme is shown in SEQ ID NO: 8, and the corresponding gene coding sequence is shown as SEQ ID NO: 7 is shown in the specification; the dDPlaseII enzyme can recognize a specific DNA double strand of which the 5 ' end is initiated by a 5 ' -CTGGATCAT-3 ' double strand sequence and the 5 ' end deoxyribonucleotide C is in a phosphorylation state and a specific polypeptide chain of which the C end is initiated by a 7 peptide N ' -MANCEHL-C ', and catalyze the dehydration condensation reaction between the phosphorylated cytosine deoxyribonucleotide C at the 5 ' end of the DNA double strand and the leucine L at the C end of the polypeptide chain to form O = P-C = O construction phosphorus-carbon bond, so that the double-strand DNA and the polypeptide are interconnected by covalent bondsAre connected together; the double-stranded DNA and polypeptide ligation product dDPII has a maximum absorption peak at 372nm, and the peak is a characteristic absorption peak and can be used for measuring the reaction activity of dDPlaseII ligase. The reaction system for dplasteii ligase was: (1) 1 ng/. mu.L-100 ng/. mu.L of a specific DNA duplex; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer, prepared from 450mM Tris-HCl, 100mM Mg, pH 7.82+80mM NaCl, 20mM MATP and 8mM Triton X-100, and adding 0.1 mu L of ligase buffer solution into each 1 mu L of reaction system; (4) 1 μ g of dplaseii enzyme; (5) and (5) adding deionized water to the required volume. Wherein the specific DNA double strand is a DNA double strand of which 5 '-end is initially a 5' -CTGGATCAT-3 'double strand sequence and 5' -end deoxyribonucleotide C is in a phosphorylated state, and the specific polypeptide is a polypeptide chain of which C-end is initiated by a peptide 7 of N '-MANCEHL-C'. The optimal reaction temperature range of the dDPlaseII ligase is 35-45 ℃, the ligation reaction time is 3-10 min, and the reaction system can be placed at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely terminated.
The novel nucleic acid polypeptide ligase, the enzymatic reaction characteristic and the using method thereof provided by the invention can lay a foundation for the novel nucleic acid polypeptide ligase serving as a novel tool enzyme for genetic engineering and genetic analysis and the application of the novel nucleic acid polypeptide ligase in the fields of nucleic acid analysis, nucleic acid marking and the like.
Drawings
FIG. 1 is a schematic diagram of a special DNA structure obtained from the sequencing analysis of a dry straw micro-ecological metagenome, which mainly comprises a promoter I, X gene, a short peptide gene and a leader DNA fragment.
FIG. 2 shows the verification of the ligation product of R9 and P7 by protein X.
Fig. 3 is a schematic diagram of O = P-C = O structural phosphorus carbon bonds.
FIG. 4 is a full-wavelength scanning spectrum of the R9 and P7 ligation product RP under the action of single-stranded RNA peptide ligase sRPPlaseI, and the characteristic absorption peak is at 351nm wavelength.
FIG. 5 is a full wavelength scanning spectrum of the ligation product sDP of sD9 and P7 under the action of single-stranded DNA peptide ligase sDPlaseI, with a characteristic absorption peak at a wavelength of 358 nm.
FIG. 6 is a full wavelength scanning spectrum of dD9 and P7 ligation product dDPI with double stranded DNA peptide ligase dDPlaseI, with characteristic absorption peak at 360nm wavelength.
FIG. 7 is a full wavelength scanning spectrum of dD9 and P7 ligation product dDPII with double stranded DNA peptide ligase dDPlaseII, with a characteristic absorption peak at 372nm wavelength.
FIG. 8 is the difference between the double stranded DNA peptide ligases dDPlaseI and dDPlaseII for the dD9 and P7 ligation reactions.
Detailed Description
The invention is further illustrated by the following examples.
Example 1 enzymes catalyzing the ligation of specific RNA Single strands and specific Polypeptides
The applicant utilizes the metagenome sequencing technology to research the functional genome of a dry straw micro-ecosystem in a Fujian region in the earlier stage, and through splicing analysis of sequencing data, the functional genome discovers that similar special DNA structures are contained at the upstream of more than ten different gene segments, and the special DNA structures are shown in figure 1 by taking cellulase (specifically, endoglucanase, EC.3.2.1.4, a main component in a cellulase system) genes as an example. The immediate vicinity of the front ends of more than ten genes such as cellulase and the like all contain two ORFs (open reading frames), and the special DNA structure taking cellulase genes as an example comprises an X gene (the sequence of which is shown as SEQ ID NO: 1) with the length of 1362bp and a short peptide gene (the sequence of which is shown as SEQ ID NO: 9) with the length of 24 bp. The polypeptide sequence coded by the short peptide gene is N '-MANCEHL-C' (shown as SEQ ID NO: 10), which sequentially corresponds to 7 amino acids of N '-methionine-alanine-asparagine-cysteine-glutamic acid-histidine-leucine-C', N 'represents the N end of the polypeptide chain, and C' represents the C end of the polypeptide chain. The X gene and the short peptide gene have unknown functions, and share one promoter (promoter I in the figure), and the gene structure product is presumed to be a component of the cellulose degrading enzyme complex because the promoter is arranged at the front end of the cellulase gene and is close to the cellulase gene. In addition, a 9-nucleotide short DNA double strand, i.e., 5 '-ATGATCCAG-3' (complementary DNA strand sequence is 3 '-TACTAGGTC-5', corresponding to transcription sequence is 5 '-AUGAUCCAG-3' short RNA sequence), is present between the cellulase gene promoter (promoter II in the figure) and the initiation codon, and is also present with the X gene and the short peptide gene, and contains similar short DNA double strands before the initiation codon of more than ten genes, and is referred to as leader DNA fragment herein.
In order to explore the role of the specific gene construct (mainly comprising promoter I, X gene, short peptide gene and leader DNA fragment) shown in fig. 1 in the cellulose complex enzyme system, it was subjected to gene cloning and protein expression together with cellulase gene: the primers are designed to amplify the gene structure (containing cellulase genes) shown in figure 1, recombinant plasmids are constructed and transferred into escherichia coli engineering bacteria for exogenous expression, and then separation and purification are carried out, and the result shows that the expression product basically has no cellulose degradation capability (including endoglucanase activity). The transcription product of the cellulase gene, namely mRNA, is detected by using real-time fluorescent quantitative PCR, the corresponding cellulase protein cannot be detected by using Western blot, and the detected protein band size is consistent with that of an X gene product; in addition, the presence of the N '-MANCEHL-C' polypeptide was also detected, indicating that the polypeptide gene was also successfully expressed. Generally speaking, in the constructed recombinant escherichia coli exogenous expression system, the cellulase gene is transcribed into mRNA but is not translated into cellulase protein, and the result shows that the translation process of the cellulase mRNA is blocked, while the adjacent X gene and leader DNA fragment can successfully express corresponding protein and polypeptide. .
Further analysis shows that for an escherichia coli engineering bacteria system introduced with the recombinant plasmid with the cellulase complex gene structure shown in fig. 1, the length of the mRNA of the extracted cellulose gene analyzed on denatured RNA electrophoresis by referring to RNA Marker does not accord with the theory, and the actual length is larger than the theoretical length. In-depth analysis (Qubit4.0) revealed that the mRNA is actually a complex of mRNA and polypeptide, a short peptide is linked to the 5' end of the mRNA, and the short peptide is the encoded product of the short peptide gene shown in FIG. 1 by RNase enzyme digestion and mass spectrometry (see example 2 for related analysis methods and procedures). Normally, mRNA and polypeptide do not ligate spontaneously, so it is assumed that the X gene expression product is an enzyme that catalyzes the ligation of a particular mRNA and a particular polypeptide. Further cloning of the X gene for expression purification is required in order to explore its characteristics.
Example 2 clonal expression of the X Gene and exploration of the X protein Performance
Primers 5'-ATGCGGACGCGCCACAGC-3' and 5'-CTACATCTGACGTCGAAGG-3' were designed based on the X gene sequence (SEQ ID NO: 1) to amplify the X gene (refer to conventional PCR system and conditions, annealing temperature: 51 ℃ C.), the X gene was expressed by cloning using the recombinant protein E.coli expression and purification system (pET Express & Purify Kits) of Takara, Japan according to the instructions, and the X protein (X gene-encoding expression product) was isolated and purified using the histidine tag attached to the fusion protein, and the final purified X protein concentration was 0.18. mu.g/ml as determined by Qubit4.0, and its amino acid sequence was as shown in SEQ ID NO: 2, respectively. As can be seen from example 1, protein X may be a ligase that catalyzes the ligation of a specific RNA and a specific polypeptide, and since protein X has been successfully expressed exogenously and isolated and purified, its properties can be further verified and studied. Since the short peptide sequence N ' -MANCEHL-C ' and the short leader RNA single-stranded sequence 5 ' -AUGAUCCAG-3 ' forms (the leader DNA fragment and cellulase gene are transcribed as described above, and mRNA thereof is present, and the short leader RNA sequence is found at the 5 ' end as shown in FIG. 1, and is transcribed from the leader DNA fragment) are ubiquitous, it is presumed that the X ligase mainly recognizes and ligates the short peptide sequence and the short leader RNA sequence, thereby blocking the translation of mRNA ligated to the short leader RNA (e.g., the cellulase gene mRNA in example 1) into protein.
The short peptide P7 (FIG. 1 short peptide gene coding product) of 7 amino acids N '-MANCEHL-C' was synthesized by Kinsley Biotechnology Ltd and the purity was not less than 95%. 5 '-P-AUGAUCCAG-B-3' short leading RNA single strand R9 of 9 ribonucleotides was synthesized simultaneously (FIG. 1 leading DNA fragment transcript, the 5 'end A ribonucleotide of which was monophosphorylated and denoted P; A in the RNA strand herein refers to adenine ribonucleotide, U refers to uracil ribonucleotide, C refers to cytosine ribonucleotide, G refers to guanine ribonucleotide), and Biotin (Biotin, denoted B) was modified at the 3' end ribonucleotide G to be separated using streptavidin-coated magnetic beads. All references herein to a phosphorylation modification refer to the attachment of the modified phosphate group to the 5 th carbon atom of a five carbon sugar of a ribonucleotide (or deoxyribonucleotide), as in a natural monophosphate or triphosphate mononucleotide; in addition, triphosphate modification may also be applicable, however, in view of practical convenience in using monophosphate, the following is not specified one by one for the sake of simplicity; as used herein, the 5 'terminal or 3' terminal nucleotide refers to the first nucleotide of the corresponding terminus, i.e., the terminal-most nucleotide. The binding of biotin to streptavidin is the strongest non-covalent interaction known in nature today and is commonly used for the isolation, purification, and analysis of particular nucleic acids or proteins. A mixed reaction system of protein X was prepared in a PCR tube according to Table 1, and placed in a PCR apparatus at 37 ℃ for 30 min. The components related in the reaction system are all prepared by RNase-free water, and the consumables are all treated by the RNase removal. Since the 3' -terminal ribonucleotide G of the short RNA single strand R9 has a biotin modification, R9 in the reaction system was captured after the reaction was completed by streptavidin magnetic beads (Dynabeads MyOne T1) from Sammarvying, USA according to the method described in the specification. After R9 was captured, RNase I (Amersham aviation, where RNA can be completely digested into single nucleotides) was added and RNA digestion was performed according to the protocol. After the RNA digestion product is purified, the RNA digestion product is sent to Beijing Baitacg Biotechnology Limited for mass spectrometry analysis. If the protein X can recognize and connect the short lead RNA single strand R9 and the short peptide sequence P7, the connection compound is digested by RNase I to obtain a connection object of the short peptide sequence P7 and the 5' terminal nucleotide A of the short lead RNA single strand R9, and finally the connection object is verified by molecular weight by mass spectrometry, wherein the specific principle and the process are shown in detail in FIG. 2 (B in FIG. 2 represents biotin modification).
The mass spectrum showed that the major peak corresponding to the molecular weight of N '-MANCEHL-A (relative molecular weight: about 1146.1, A in A represents A ribonucleotide) and the minor peak corresponding to the molecular weight of C' -L-A (relative molecular weight: about 460.4, C '-L represents C-terminal amino acid, L amino acid, and A in A represents A ribonucleotide) were present, but no peak corresponding to the molecular weight of N' -M-A was found. The main peak results indicate that R9 and P7 are linked together; the secondary peak results confirmed that the linkage of R9 and P7 was a P-C phosphorus-carbon bond (specifically, the configuration was O = P-C = O, i.e., the phosphorus atom in the phosphorus-oxygen double bond P = O and the carbon atom in the carbon-oxygen double bond O = C were covalently linked, see fig. 3, which was formed by dehydration condensation of the phosphate group of a ribonucleotide and the carboxyl group of L amino acid) between the 5 '-ribonucleotide a of R9 and the C' -terminal amino acid L of P7. In conclusion, protein X, a newly discovered single-stranded RNA peptide ligase, is indicated by the abbreviation sRPoseI (i.e., single-stranded for single-stranded RNA and polypeptide), and catalyzes the covalent linkage of R9 and P7, and the specific ligation product of RNA single strand and polypeptide is indicated by RP.
TABLE 1 protein reaction System
Components Adding amount of
1. mu.g/. mu.L of synthetic RNA single strand R9 1μL
1 mu g/mu L synthetic short peptide P7 1μL
Ligase buffer (composed of 500mM Tris-HCl, 100mM Mg at pH 7.5)2+10mM ATP and 10mM DTT) 1μL
X protein 1μg
Ultra-pure water Make up to 10. mu.L
Example 3 detection of reaction product of Single-stranded RNA peptide ligase sRPoseI and enzymatic characterization
Examples 1 and 2 show that sRPoseI is a ligase that catalyzes the ligation of a specific single-stranded RNA to a specific polypeptide, and that a simple ligation assay should be established in order to further explore its enzymatic properties. Since the reaction product catalyzed by sRPlaseI ligase is a covalently linked (O = P-C = O building a phosphorus-carbon bond) complex of RNA single strands and polypeptides, an attempt can be made to determine the absorption spectrum characteristics thereof in order to attempt reaction determination using a simple spectrophotometric method. The reaction products of Table 1 of example 2, 3. mu.l each of R9, P7 and the blank reaction system were scanned at a full wavelength in the range of 200nm to 1000nm using an Epoch microplate reader (Biotek, USA), and the results of the reaction products are shown in FIG. 4. The results show that the ligation reaction complex of RNA single strand and polypeptide (designated as RP) shows a maximum absorption at 351nm, while none of R9, P7 and the blank reaction system shows this peak, indicating that the 351nm wavelength peak is the characteristic absorption peak of the ligation complex RP, which is due to the specific absorption of the phosphorus-carbon bond of the O = P-C = O configuration. Because the RNA is a connection product of RNA and polypeptide, absorption peaks respectively appear at wavelengths of about 215nm, 260nm and 280nm, but under the influence of a reaction system, the wavelengths are not suitable for measuring RP. From this, it is found that absorbance at 351nm is a simple and effective method for measuring the sRPoseI ligase reaction (product analysis method).
To explore the substrate specificity of sRPlaseI ligase, attempts were made to alter the R9 and/or P7 fragments. By altering the R9 fragment, including by reduction and/or replacement of some of the ribonucleotides, the system showed no significant absorption peak at 351nm after the end of the ligation reaction, indicating that no phosphorus-carbon bond product of O = P-C = O construction was formed, i.e. no ligation reaction was performed. Likewise, by altering the P7 fragment, including by reducing and/or replacing some of the amino acids, the system also showed no significant absorption peak at 351nm after the end of the ligation reaction, indicating that no phosphorus-carbon bond product of O = P-C = O structure was formed, i.e., no ligation reaction proceeded. It was thus shown that sRPoseI ligase-catalyzed ligation was based on the recognition of the stringent R9 and P7 fragments, which also confirms that the gene constructs similar to R9 and P7 appeared in the first few genes mentioned in example 1, that the R9 and P7 sequences were conserved for sRPoseI ligase, and that no other sequence forms of the genes corresponding to R9 and P7 linked to their genes were found. However, since sRPoseI ligase mediates the ligation of the 5 'terminal ribonucleotide of R9 and the C-terminal amino acid of P7, extension of the 3' terminal ribonucleotide chain of R9 and/or the N-terminal amino acid chain of P7 does not theoretically affect the progress of the ligation reaction while retaining R9 and P7. 5 ' -P-AUGAUCCAG-Rn-3 ' (where P represents monophosphorylated modification) and N ' -Pm-MANCEHL-C ' were used as substrates, where Rn is a single-stranded RNA fragment linked to the 3 ' end of R9, and 3 fragments of different lengths and sequences R1, R2 and R3 were tried (in view of sequence synthesis techniques and cost, R1-R3 selected mRNA regions corresponding to glutathione, human insulin A chain and human insulin B chain, respectively, and glutathione was a virtual mRNA sequence), whose ribonucleotide sequences were shown in SEQ ID NO: 11-SEQ ID NO: 13 (9 nt, 63nt, and 90nt in length, respectively); pm is a polypeptide fragment connected with the N-terminal of P7, and 3 fragments of different lengths and sequences, P1, P2 and P3 (P1-P3 correspond to R1-R3 respectively and correspond to glutathione, a human insulin A chain and a human insulin B chain respectively) are tried, and the amino acid sequences of the fragments are shown as SEQ ID NO: 14-16 (3 aa, 21aa and 30aa in length, respectively), and a total of 9 combinations of two substrates (RNA single strand and polypeptide) were used, and with reference to table 1, the sRPlaseI ligase-mediated reaction system detected a significant absorption peak at 351nm, indicating that a phosphorus-carbon bond product with O = P-C = O structure was formed, i.e., a ligation reaction was performed. This is also consistent with the observation in example 1 that the cellulase gene is transcribed but not translated into protein, because the short leader RNA single strand is attached to the 5 'end of the long mRNA transcribed from the cellulase gene, and P7 is attached to the short leader RNA single strand R9 at the 5' end by sRPlaseI ligase (the expression product of the X gene immediately adjacent to the cellulase in the specific gene configuration of fig. 1), and the cellulase mRNA cannot be recognized and translated.
As can be seen, sRPlaseI ligase is capable of ligating RNA single strands with a 5 ' terminus initially containing intact R9 and a 5 ' terminal ribonucleotide a in a phosphorylated state (i.e., 5 ' -P-R9-3 ', P indicates that the 5 ' terminal ribonucleotide of R9 is monophosphorylated and P indicates other RNA sequence at the 3 ' terminus) and a C-terminus initially containing intact P7 and a specific polypeptide chain as a substrate (i.e., N ' -P7-C ', -indicating other polypeptide sequence at the N terminus), catalyzing covalent ligation of RNA single strands and polypeptide chains, particularly the formation of a phosphorus-carbon bond with O = P-C = O configuration between the 5 ' terminal ribonucleotide a of RNA and the C-terminal amino acid L of the polypeptide. The 5 'terminal ribonucleotide refers to the first ribonucleotide at the 5' terminus. The phosphorylated form of the nucleotide refers to a modified or naturally occurring phosphate group attached to the 5 th carbon atom of the five carbon sugar of the ribonucleotide as in the case of the natural monophosphate or triphosphate mononucleotide; in addition, triphosphate modification may also be applicable, however, monophosphate may be conveniently used in consideration of practical use, and is not specifically indicated below for the sake of simplicity.
With reference to Table 1, the optimum reaction buffer system and temperature of sRPISeI ligase were investigated using different buffers and temperatures according to Table 2 using R9 and P7 as substrates. Buffers A and B were 2 commonly used ligase buffers, buffer A was prepared from 500mM Tris-HCl, 100mM Mg at pH 7.52+10mM ATP and 10mM DTT; buffer B was composed of 450mM Tris-HCl, 100mM Mg, pH 7.82+80mM NaCl, 20mM MATP and 8mM Metriton X-100. The amount of sRPoseI ligase added was 1. mu.g, and the reaction time was 30 min. After completion, 3. mu.L of the reaction product was collected, and the absorbance thereof was measured at 351nm using an Epoch microplate reader (Biotek, USA), and the results are shown in Table 2. As can be seen from Table 2, the absorbance measured for the reaction product was higher in the buffer A system than in buffer B at each temperature, indicating that buffer A is more suitable for sRPoseI ligase. In the buffer A group, the absorbance measured at 37 ℃ for the reaction product was the highest (1.28), indicating that 37 ℃ is the optimum reaction temperature for sRPoseI ligase. Furthermore, the results in Table 2 show that the optimum reaction temperature range for sRPISeI ligase was 30 ℃ to 40 ℃. Using the aforementioned 5' -P-AUGAUCCAG-Rn-3 '(P indicates that 5' terminal A ribonucleotide is phosphorylated) and N '-Pm-ManCEHL-C' are used as substrates, and the optimal buffer solution and the optimal temperature condition are consistent with the R9 and P7 substrate groups.
TABLE 2 reactivity of sRPISeI ligase in different reaction buffer systems and temperature gradients
Figure DEST_PATH_IMAGE001
Extension of the reaction time to 60min and an increase in the amount of sRPoseI ligase to 2. mu.g at buffer A and 37 ℃ also resulted in a reaction product with an absorbance of 1.28 at 351nm, indicating that the reaction had proceeded completely for 30min at buffer A and 37 ℃. The reaction time was shortened to 10min while keeping the original system and conditions unchanged, and it was found that the absorbance of the reaction product at 351nm was also 1.28, and thus the reaction proceeded sufficiently for 10 min. Keeping the original system and conditions unchanged, preserving the temperature of the sRPoseI ligase reaction system at 80 ℃ for 3min (incubating the basic reaction system at 80 ℃ for 15min, then adding the sRPoseI ligase), and continuing the reaction, wherein the absorbance of the reaction product at 351nm is not significantly different from that of a blank control (the blank control is 0.08, and the pre-incubation system at 80 ℃ is 0.13) to indicate that the reaction is terminated, so that the temperature can be preserved for 3min at 80 ℃ after the reaction is finished to completely terminate the reaction.
In summary, the present invention provides a single-stranded RNA peptide ligase sRPlaseI for catalyzing covalent ligation of a specific single-stranded RNA to a specific polypeptide, wherein the amino acid sequence of sRPlaseI is as shown in SEQ ID NO: 2, and the corresponding gene coding sequence is shown as SEQ ID NO: 1 is shown in the specification; the sRPlasII enzyme can recognize a specific RNA single chain of which the 5 ' end is initiated by a 5 ' -AUGAUCCAG-3 ' sequence and the 5 ' end ribonucleotide A is in a phosphorylated state and a specific polypeptide chain of which the C end is initiated by a 7-peptide N ' -MANCEHL-C ', and catalyze a dehydration condensation reaction between the adenine ribonucleotide A at the 5 ' end of the RNA single chain and leucine L at the C end of the polypeptide chain to form a phosphorus-carbon bond with O = P-C = O structure, so that the single-stranded RNA and the polypeptide are connected with each other by covalent bonds. Single strandThe RNA-polypeptide ligation product RP has a maximum absorption peak at a wavelength of 351nm, which is the characteristic absorption peak. The reaction system for sRPlaseI ligase is: (1) 1 ng/mu L-100 ng/mu L of specific RNA single strand; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer consisting of 500mM Tris-HCl, 100mM Mg, pH 7.52+10mM ATP and 10mM DTT, and adding 0.1 mu L ligase buffer solution to each 1 mu L reaction system; (4) and (5) adding deionized water to the required volume. Wherein, the specific RNA single strand refers to the RNA single strand of which the 5 'end is started to be 5' -AUGAUCCAG-3 'sequence and the 5' end ribonucleotide A is in a phosphorylation state, and the specific polypeptide refers to the polypeptide chain of which the C end is started to be 7 peptides of N '-MANCEHL-C'. The optimal reaction temperature range of sRPoseI ligase is 30-40 ℃, the ligation reaction time is 10-15 min, and the reaction system can be kept at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely stopped.
Example 4 DNA peptide ligase that catalyzes ligation of specific DNA Single strands or specific DNA double strands to specific Polypeptides
In addition to single-stranded RNA, the nucleic acid forms commonly found in vivo and in the field of molecular biology include double-stranded DNA and single-stranded DNA, and therefore the gene encoding the single-stranded RNA peptide ligase sRPoseI (i.e., the X gene in FIG. 1, the sequence shown in SEQ ID NO: 1) was further engineered by bioinformatic design in order to construct a specific DNA peptide ligase. The substrate binding site and the catalytic activity center of the single-stranded RNA peptide ligase sRPoseI were predicted by bioinformatic analysis, a series of modified genes were obtained focusing on changing the coding sequences of these key sites by customization, and the modified enzymes were obtained by cloning, expressing and isolating and purifying according to the instructions using the recombinant protein E.coli expression and purification system (pET Express & Purify Kits) of Takara, Japan, with reference to the method in example 2. Considering the stringency of ligase on the substrates, P7 was still selected for the polypeptides in both substrates, and the DNA strand (5 '-P-ATGATCCAG-B-3', sD9, P for monophosphorylated modification and B for biotin modification) or the DNA strand (5 '-P-ATGATCCAG-B-3', double-stranded form, complementary strand 3 '-TACTAGGTC-P-5', dD9, P for monophosphorylated modification and B for biotin modification) was selected for the corresponding DNA strand R9. Wherein short single-stranded DNA (sD 9) is directly synthesized by Kinserray Biotechnology Ltd; and the short double-stranded DNA fragment, namely dD9, firstly entrusts Kinsley Biotechnology Limited company to respectively synthesize complementary strands, then equally (1.5 mu g/mu L) two complementary single-stranded DNAs are mixed in an annealing system buffer solution, the temperature is kept for 16h at 25 ℃, then a double-stranded product is purified, the concentration is measured by adopting Qubit4.0, and the preparation of the double-stranded DNA is completed by the company.
The modified enzyme reaction system was prepared according to Table 3 and placed in a PCR instrument at 37 ℃ for 30 min. Single-stranded DNA and reaction products of double-stranded DNA with P7 were designated sDP and dDP (collectively, DP), respectively. Since the single-stranded RNA peptide ligase sRPlaseI can catalyze R9 and P7 to form a product RP containing a phosphorus-carbon bond with O = P-C = O configuration, which has characteristic absorption at 351nm wavelength. In this regard, the reaction product of the DNA strand acted on by the engineered enzyme system and P7 was scanned over all wavelengths to see if it had characteristic absorption peaks at 351nm or other nearby wavelengths, thereby allowing for easy screening of engineered enzymes that could be used to link sD9 (or dD 9) to P7. On the basis of full-wavelength scanning primary screening, for candidate modified enzyme systems, referring to the method in example 2, streptavidin-coated magnetic beads are used for capturing DNA chains (sD 9 or dD9, namely D9) with biotin labels, DNA exonuclease (digestible single-stranded DNA and double-stranded DNA) is used for digesting a ligation reaction system product according to the method in the specification, and the product is purified and then sent to the company for mass spectrometry detection and analysis.
TABLE 3 modified enzyme reaction systems
Components Adding amount of
Mu.g/. mu.L of DNA single strand sD9 or DNA double strand fragment dD9 1μL
1 mu g/mu L synthetic short peptide P7 1μL
Ligase buffer (composed of 500mM Tris-HCl, 100mM Mg, pH 7.5)2+10mM ATP and 10mM DTT) 1μL
Engineering enzymes 1μg
Ultrapure water Make up to 10 μ L
Through screening of 34 kinds of modified enzymes, 1 kind of candidate high-reactivity specific single-stranded DNA polypeptide ligase is found, which is marked as sDPlaseI (i.e. one strand for single-stranded DNA and polypeptide), and the gene sequence of the ligase is shown as SEQ ID NO: 3, and the corresponding amino acid sequence is shown as SEQ ID NO: 4 is shown in the specification; 2 candidate highly reactive specific double-stranded DNA polypeptide ligases, designated as dDPlaseI (i.e. ligand I for double-stranded DNA and polypeptide) and dDPlaseI (i.e. ligand II for double-stranded DNA and polypeptide), have the gene sequences as shown in SEQ ID NO: 5 and SEQ ID NO: 7, and the corresponding amino acid sequences are respectively shown as SEQ ID NO: 6 and SEQ ID NO: shown in fig. 8. Full wavelength scan patterns for the sDPlaseI, dDPlaseI and dDPlaseII enzyme reaction systems are shown in fig. 5-7, respectively. The products of the 3 DNA polypeptide ligase reaction systems have absorption peaks at wavelengths of about 215nm, 260nm and 280nm, and when the streptavidin-coated magnetic beads are used for capturing a substance containing a biotin label and then full-wavelength scanning measurement is carried out, the 3 wavelength peaks still exist, and the 3 wavelength peaks are just the characteristic absorption peaks of DNA and polypeptide, and the existence of a DNA and polypeptide compound is verified from the side. In contrast, the enzyme reaction systems of sDPlaseI, dDPlaseI and dDPlaseII each exhibited unique characteristic absorption wavelengths of 358nm, 360nm and 372nm, which are very close to the characteristic absorption wavelength of 351nm of the single-stranded RNA polypeptide complex RP in example 3, and are likely to be characteristic absorption peaks where O = P-C = O constructing a phosphorus-carbon bond, but slightly different characteristic absorption wavelengths were caused due to the inconsistency between the nucleotide (ribonucleotide or deoxyribonucleotide) forming a phosphorus-carbon bond with L amino acid and its surrounding environment. And verifying by mass spectrometry on the basis of determining a characteristic absorption peak by full-wavelength scanning to screen a candidate DNA polypeptide ligase system.
Further, the mass spectrum of the reaction product of the sdplaseI enzyme showed the occurrence of a major peak corresponding to the molecular weight of N ' -MANCEHL-A (relative molecular mass: 1130.2, -A in A represents the 5 ' -terminal nucleotide of sD9, i.e., A deoxyribonucleotide), and in addition, a peak corresponding to the molecular weight of C ' -L-A in the minor peak (relative molecular mass: 444.4, C ' -L represents the C-terminal amino acid of P7, i.e., L amino acid, -A in A represents the 5 ' -terminal nucleotide of sD9, i.e., A deoxyribonucleotide). The mass spectrometry results showed that sD9 and P7 had a linkage that was a phosphorus-carbon bond interconnection between the 5' terminal deoxyribonucleotide a of sD9 and the C-terminal amino acid L of P7 in an O = P-C = O configuration. It is known that the sDPlaseI enzyme can catalyze the covalent linkage of sD9 and P7, and the sDPlaseI enzyme is a novel single-stranded DNA peptide ligase, and the catalyzed ligation product of a DNA single strand and a polypeptide is represented by sDP.
The mass spectrum of the dplasel enzyme reaction product showed the appearance of a major peak corresponding to the molecular weight of N ' -MANCEHL-a (relative molecular mass 1130.2, -a in a represents the 5 ' terminal nucleotide of the dD9 linker, i.e., a deoxyribonucleotide), and in a minor peak the appearance of a peak corresponding to the molecular weight of C ' -L-a (relative molecular mass 444.4, C ' -L represents the C-terminal amino acid of P7, i.e., L amino acid, -a in a represents the 5 ' terminal nucleotide of the dD9 linker, i.e., a deoxyribonucleotide). It should be noted that although the short double-stranded DNA fragment dD9 is connected to a nucleotide pair a = T at one end, under mass spectrometry conditions, the hydrogen bond of base complementary pairing between a = T will be opened, and only the deoxyribonucleotide a covalently linked to P7 will be retained. The mass spectrometry results showed that dD9 and P7 have been linked together, the linkage being a phosphorus-carbon bond interconnection between the 5' terminal deoxyribonucleotide a on the dD9 connecting strand and the C-terminal amino acid L of P7 in the O = P-C = O configuration. It is known that dDPlaseI enzyme can catalyze the covalent linkage between dD9 and P7, and dDPlaseI enzyme is a novel double-stranded DNA peptide ligase, and the catalytic ligation product of the double-stranded DNA and the polypeptide is represented by dDPI.
The mass spectrum of the dDPlasEI enzyme reaction product showed the appearance of a major peak corresponding to the molecular weight of N ' -MANCEHL-C (relative molecular mass 1106.1; C in-C denotes the 5 ' terminal nucleotide of the dD9 linker, i.e., C deoxyribonucleotide), and in the minor peak a peak corresponding to the molecular weight of C ' -L-C (relative molecular mass 420.4, C ' -L denotes the C-terminal amino acid of P7, i.e., L amino acid, and C in-C denotes the 5 ' terminal nucleotide of the dD9 linker, i.e., C deoxyribonucleotide). It should be noted that although the short double-stranded DNA segment dD9 has a C.ident.G nucleotide pair at one end, under mass spectrometry conditions, the hydrogen bond of base complementary pairing between C.ident.G will be opened, and only the deoxyribonucleotide C covalently linked to P7 will be retained. The mass spectrometry results showed that dD9 and P7 were linked together, and that dD9 and P7 were linked together by a phosphorus-carbon bond in O = P-C = O configuration between the 5' terminal deoxyribonucleotide C on one strand of dD9 and the C-terminal amino acid L of P7. It is known that dDPlaseII enzyme can catalyze the covalent linkage between dD9 and P7, and dDPlaseII enzyme is a novel double-stranded DNA peptide ligase, and the catalytic ligation product of a DNA double strand and a polypeptide is represented by dDPII.
Both dplasei and dplasei enzymes can catalyze the linkage of dD9 and P7 with a covalent bond of O = P-C = O building a phosphorus-carbon bond, with the difference that dplasei enzymes catalyze the linkage of the 5 'terminal deoxyribonucleotide a on one strand of dD9 (i.e., the 5' -P-ATGATCCAG-3 'strand) and the C-terminal amino acid L of P7 with O = P-C = O building a phosphorus-carbon bond, while dplasei enzymes catalyze the linkage of the 5' terminal deoxyribonucleotide C on the other strand of dD9 (the 5 '-P-CTGGATCAT-3' strand, i.e., the complementary strand of the 5 '-P-ATGATCCAG-3' strand) and the C-terminal amino acid L of P7 with a phosphorus-carbon bond building a O = P-C = O, as shown in fig. 8. Thus, in practical applications, for example, for nucleic acid labeling, any strand of a double strand of DNA can be labeled with dDPlaseI or dDPlaseII of the ligase of the present invention; also for example, for preventing gene expression or regulation, transcription or regulation of the expression product of either strand of the DNA duplex can be prevented by the ligase dDPlaseI or dDPlaseII of the invention.
EXAMPLE 53 exploration of the enzymatic Properties of DNA polypeptide ligases
To explore the substrate specificity of the 3 DNA polypeptide ligases, sDPlaseI, and dDPlaseII, it was attempted to alter the sD9 (or dD 9) and/or P7 fragments. By altering the sD9 (or dD 9) fragment, including the reduction and/or replacement of some of the deoxyribonucleotides, the system does not have a significant absorption peak at 358nm (or 360nm or 372 nm) after the end of the ligation reaction, indicating that no phosphorus-carbon bond product of O = P-C = O configuration is formed, i.e., no ligation reaction is performed. Likewise, by altering the P7 fragment, including by reducing and/or replacing some of its amino acids, the system also shows no significant absorption peak at 358nm (or 360nm or 372 nm) after the ligation reaction is completed, indicating that no phosphorus-carbon bond product of O = P-C = O structure is formed, i.e., no ligation reaction is performed. Thus, it was shown that the ligation catalyzed by the sDPlaseI, dDPlaseI and dDPlaseII ligases is based on the recognition of the stringent D9 (i.e., sD9 or dD 9) and P7 fragments, which are consistent with the stringent substrate sequence requirements of the single-stranded RNA polypeptide ligase sRPaseI, i.e., the 3 DNA polypeptide ligases require that the D9 and P7 recognition sequences be conserved. However, since all of the 3 DNA polypeptide ligases mediate the ligation between the 5 '-terminal deoxyribonucleotide of D9 and the C-terminal amino acid of P7, extension of the 3' -terminal deoxyribonucleotide chain on the non-ligation side of D9 and/or the N-terminal amino acid chain of P7 does not theoretically affect the ligation reaction while retaining D9 and P7. For the single-stranded DNA polypeptide ligase sDPlaseI system, a DNA single strand of 5 '-P-ATGATCCAG-Dn-3' (P represents phosphorylation modification) and N '-Pm-MANCEHL-C' are used as substrates; for a double-stranded DNA polypeptide ligase dDPlaseI system, a DNA double strand of 5 '-P-ATGATCCAG-Dn-3' (the complementary strand of the DNA double strand is 3 '-TACTAGGTC-Dn' -5 ', and Dn' is the complementary strand of Dn) and N '-Pm-ManceHL-C' are used as substrates; for a double-stranded DNA polypeptide ligase dDPlaseII system, a DNA double strand of 5 ' -P-CTGGATCAT-Dn-3 ' (the complementary strand of the DNA double strand is 3 ' -GACCTAGTA-Dn ' -5 ', and Dn ' is the complementary strand of Dn) and N ' -Pm-ManceHL-C ' are used as substrates, wherein Dn is a DNA fragment connected with the 3 ' end of the non-enzymatic connection side of D9, and as with the exploration of single-stranded RNA polypeptide ligase, 3 fragments of different lengths and sequences, D1, D2 and D3 (D1, D2 and D3 correspond to R1, R2 and R3 respectively, namely Dn is a DNA form of Rn) are tried, and the sequences of the DNA double-stranded DNA polypeptide ligase are respectively shown as SEQ ID NO: 17-19; pm is a polypeptide fragment connected with the N-terminal of P7, and 3 fragments P1, P2 and P3 (corresponding to the encoded polypeptide products of D1-D3, respectively, glutathione, human insulin A chain and human insulin B chain) with different lengths and sequences are tried, wherein the sequences of the fragments are shown in SEQ ID NO: 14-16, for each of the 3 DNA polypeptide ligases, 9 combinations of the two substrates were tried, and significant absorption peaks were consistently detected at 358nm, 360nm and 372nm in the sDPlaseI, dDPlaseI and dDPlaseII ligase-mediated reaction systems, respectively, indicating that O = P-C = O structure phosphorus-carbon bond product formation, i.e., ligation reaction was proceeding.
In conclusion, the scdlasel ligase can catalyze the covalent ligation of single DNA strands and polypeptide chains by using as a substrate a single DNA strand starting at the 5 'end as intact sD9 and having its 5' terminal deoxyribonucleotide a in phosphorylated form (i.e., 5 '-P-ATGATCCAG-' 3 '; indicates other DNA sequence at the 3' end) and a polypeptide chain starting at the C-terminal end as intact P7; dplastei ligase is capable of catalyzing the covalent ligation of DNA duplexes and polypeptide chains by using as substrates a DNA duplex starting at the 5 ' end with the complete dD9 construct and having its 5 ' end deoxyribonucleotide a in phosphorylated form (i.e. DNA duplex corresponding to 5 ' -P-ATGATCCAG-x-3 ' representing the 3 ' end of the other DNA sequence) and a polypeptide chain starting at the C-end with the complete P7; dplaseii ligase is capable of catalyzing covalent ligation of DNA duplexes and polypeptide chains by using as a substrate a DNA duplex which is constructed with the 5 ' end starting as intact dD9 and whose 5 ' end deoxyribonucleotide C is in phosphorylated form (i.e., a DNA duplex corresponding to 5 ' -P-CTGGATCAT-3 ' and representing the 3 ' end of the other DNA sequence) and a polypeptide chain whose C end starting as intact P7. The 5 '-terminal deoxyribonucleotide refers to the first deoxyribonucleotide at the 5' -terminal. By phosphorylated form of deoxyribonucleotide is meant that, like the natural monophosphate or triphosphate monodeodeoxyribonucleotide, a modified or naturally occurring phosphate group is attached to the 5 th carbon atom of the five carbon sugar of the deoxyribonucleotide; in addition, triphosphate modification may also be applicable, however, in view of practical convenience in use of monophosphate, it is not specifically indicated below for the sake of simplicity.
Referring to Table 3, using D9 (sD 9 or dD 9) and P7 as substrates, the optimal reaction buffer systems and temperatures of the 3 ligases, sDPlaseI, dDPlaseI and dDPlaseII, were investigated at their characteristic absorption wavelengths using different buffers and temperatures according to Table 4. The 2 commonly used ligase buffers, buffer A and B, were still used for the same single-stranded RNA polypeptide ligase sRPISEI probe. The addition amount of the DNA polypeptide ligase is 1 mu g, and the reaction time is 30 min. After completion, 3. mu.L of the reaction product was collected, and absorbance was measured at 358nm (sDPlaseI ligase reaction system), 360nm (dDPlaseI ligase reaction system) and 372nm (dDPlaseI ligase reaction system) using an Epoch microplate reader (Biotek, USA), and the results are shown in Table 4. As can be seen from table 4, for the scdplaei ligase, the absorbance of the reaction product was higher for the scdplaei ligase in the buffer a system than for buffer B at each temperature, indicating that buffer a is more suitable for the scdplaei ligase; whereas for dplasei and dplasei ligase, the absorbance of the reaction product was higher for the buffer B system than for buffer a at each temperature, indicating that buffer B is more suitable for both dplasei and dplasei ligase. For the sDPlaseI ligase, the absorbance of the reaction product was measured to be the highest in buffer A group at 37 ℃ (1.37), indicating that 37 ℃ is the optimal reaction temperature for sDPlaseI ligase. The absorbance measured for dplasei and dplasei ligases was highest for the reaction product at 40 ℃ (1.44 and 1.48, respectively) in buffer B group, indicating that 40 ℃ is the optimal reaction temperature for dplasei and dplasei ligases. In addition, the results in Table 4 show that the optimal reaction temperature range for sDPlaseI ligase is 30 ℃ to 40 ℃, and the optimal reaction temperature ranges for dDPlaseI and dDPlaseII ligases are both 35 ℃ to 45 ℃.
The research on the specificity of the same substrate, for a single-stranded DNA polypeptide ligase sDPlaseI system, a DNA single strand of 5 '-P-ATGATCCAG-Dn-3' and N '-Pm-MANCEHL-C' are used as substrates; for a double-stranded DNA polypeptide ligase dDPlaseI system, a DNA double strand of 5 '-P-ATGATCCAG-Dn-3' and N '-Pm-MANCEHL-C' are used as substrates; for a double-stranded DNA polypeptide ligase dDPlaseII system, a DNA double strand of 5 '-P-CTGGATCAT-Dn-3' and N '-Pm-ManceHL-C' are used as substrates, and for the 3 DNA polypeptide ligase, the optimal buffer solution and the optimal temperature condition are consistent with those of a D9 substrate group and a P7 substrate group.
TABLE 43 reactivity of DNA polypeptide ligases in different reaction buffer systems and temperature gradients
Figure 494344DEST_PATH_IMAGE002
Referring to the study of the reaction conditions of sRPISeI ligase in example 3, it was found that the ligation reaction was sufficiently performed by adding 1. mu.g of sDPlaseI ligase to buffer A at 37 ℃ for 10min by changing the amount of enzyme added and the reaction time in the reaction system (see the system in Table 3); in buffer B and 40 deg.C (refer to Table 3 system), adding 1. mu.g dDPlaseI ligase (or dDPlaseI ligase) takes 8min to fully perform the ligation reaction. For the sDPlaseI, dDPlaseI and dDPlaseI ligases, the reaction was stopped completely by incubation at 80 ℃ for 3 min.
In summary, the present invention provides a single-stranded DNA peptide ligase sDPlaseI for catalyzing the covalent linkage of a specific single-stranded DNA and a specific polypeptide, the amino acid sequence of which is as shown in SEQ ID NO: 4, and the corresponding gene coding sequence is shown as SEQ ID NO: 3 is shown in the specification; the sDPlaseI enzyme can recognize a specific DNA single chain of which the 5 ' end is initially provided with a 5 ' -ATGATCCAG-3 ' sequence and the 5 ' end deoxyribonucleotide A is in a phosphorylation state and a specific polypeptide chain of which the C end is initially provided with a 7 peptide N ' -MANCEHL-C ', and catalyze the dehydration condensation reaction between the adenine deoxyribonucleotide A at the 5 ' end of the DNA single chain and the leucine L at the C end of the polypeptide chain to form a phosphorus-carbon bond with O = P-C = O structure, so that the single-chain DNA and the polypeptide are connected with each other by covalent bonds. The single-stranded DNA and polypeptide ligation product sDP has a maximum absorption peak at a wavelength of 358nm,this peak is its characteristic absorption peak. The reaction system for the sDPlaseI ligase was: (1) 1 ng/. mu.L-100 ng/. mu.L of a specific DNA single strand; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer consisting of 500mM Tris-HCl, 100mM Mg, pH 7.52+10mM ATP and 10mM DTT, and 0.1. mu.L ligase buffer solution is added to each 1. mu.L reaction system; (4) deionized water to make up to the required volume. Wherein the specific DNA single strand is a DNA single strand having 5 '-end starting with 5' -ATGATCCAG-3 'sequence and 5' -end deoxyribonucleotide A in phosphorylated state, and the specific polypeptide is a polypeptide chain having C-end starting with 7 peptides N '-MANCEHL-C'. The optimal reaction temperature range of the sDPlaseI ligase is 30-40 ℃, the ligation reaction time is 5-15 min, and the reaction system can be kept at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely stopped.
The invention also provides a double-stranded DNA peptide ligase dDPlaseI for catalyzing covalent linkage of specific double-stranded DNA and specific polypeptide, wherein the amino acid sequence of the double-stranded DNA peptide ligase dDPlaseI is shown as SEQ ID NO: 6, and the corresponding gene coding sequence is shown as SEQ ID NO: 5 is shown in the specification; the dDPlaseI enzyme can recognize a specific DNA double chain of which the 5 ' end is initiated to be a 5 ' -ATGATCCAG-3 ' double-chain sequence and the 5 ' end deoxyribonucleotide A is in a phosphorylation state and a specific polypeptide chain of which the C end is initiated to be a 7 peptide of N ' -MANCEHL-C ', and catalyze the dehydration condensation reaction between the adenine deoxyribonucleotide A at the 5 ' end of the DNA double chain and the leucine L at the C end of the polypeptide chain to form a phosphorus-carbon bond with O = P-C = O structure, so that the double-chain DNA and the polypeptide are connected with each other by covalent bonds. The double-stranded DNA and polypeptide ligation product dDPI has a maximum absorption peak at a wavelength of 360nm, which is its characteristic absorption peak. The reaction system for dplasei ligase is: (1) 1 ng/. mu.L-100 ng/. mu.L of a specific DNA duplex; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer consisting of 450mM Tris-HCl, 100mM Mg, pH 7.82+80mM NaCl, 20mM MATP and 8mM Triton X-100, and adding 0.1 mu L of ligase buffer solution into each 1 mu L of reaction system; (4) deionized water to make up to the required volume. Wherein the specific DNA double strand is a 5 '-end double strand sequence of 5' -ATGATCCAG-3 'and the 5' -end deoxyribonucleotide A is phosphorylatedThe term "DNA double-stranded" refers to a polypeptide chain that is C-terminally initiated with the 7 peptide N '-MANCEHL-C'. The optimal reaction temperature range of the dDPlaseI ligase is 35-45 ℃, the ligation reaction time is 3-10 min, and the reaction system can be placed at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely terminated.
The invention also provides another double-stranded DNA peptide ligase dDPlaseII for catalyzing covalent linkage of specific double-stranded DNA and specific polypeptide, wherein the amino acid sequence of the double-stranded DNA peptide ligase dDPlaseII is shown as SEQ ID NO: 8, and the corresponding gene coding sequence is shown as SEQ ID NO: 7 is shown in the specification; the dDPlaseII enzyme can recognize a specific DNA double strand of which the 5 ' end is initiated by a 5 ' -CTGGATCAT-3 ' double strand sequence and the 5 ' end deoxyribonucleotide C is in a phosphorylation state and a specific polypeptide chain of which the C end is initiated by a 7 peptide N ' -MANCEHL-C ', and catalyze the dehydration condensation reaction between the cytosine deoxyribonucleotide C at the 5 ' end of the DNA double strand and the leucine L at the C end of the polypeptide chain to form O = P-C = O construction phosphorus-carbon bond, so that the double-stranded DNA and the polypeptide are connected with each other by covalent bonds. The double-stranded DNA and polypeptide ligation product dDPII has a maximum absorption peak at a wavelength of 372nm, which is a characteristic absorption peak. The reaction system for dplaseii ligase is: (1) 1 ng/. mu.L-100 ng/. mu.L of a specific DNA duplex; (2) 1 ng/. mu.L-100 ng/. mu.L of a particular polypeptide; (3) ligase buffer consisting of 450mM Tris-HCl, 100mM Mg, pH 7.82+80mM NaCl, 20mM MATP and 8mM Triton X-100, and adding 0.1 mu L of ligase buffer solution into each 1 mu L of reaction system; (4) and (5) adding deionized water to the required volume. Wherein the specific DNA double strand is a DNA double strand of which 5 '-end is initially a 5' -CTGGATCAT-3 'double strand sequence and 5' -end deoxyribonucleotide C is in a phosphorylated state, and the specific polypeptide is a polypeptide chain of which C-end is initiated by a peptide 7 of N '-MANCEHL-C'. The optimal reaction temperature range of dDPlaseII ligase is 35-45 ℃, the ligation reaction time is 3-10 min, and the reaction system can be kept at 80 ℃ for 3min after the ligation reaction is finished, so that the reaction can be completely stopped.
In summary, the present invention provides 4 novel nucleic acid polypeptide ligases, including 1 specific single-stranded RNA peptide ligase sRPlaseI, 1 specific single-stranded DNA peptide ligase stdplasei and 2 specific double-stranded DNA peptide ligases dplasei and dplasei, which can be used as tool enzymes for genetic engineering and genetic analysis, and have great application prospects in the fields of nucleic acid labeling and nucleic acid analysis, etc.
Sequence listing
<110> Fujian Chengxi Biotech Co., Ltd
<120> Single-stranded RNA peptide ligase sRPeseI and method of use thereof
<160> 19
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1362
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgcggacgc gccacagcag aactctgcta ctcgagcatc ttgccacaga aagacgacgt 60
ttagctccgt ggaacatagg gtccgcttca acaagacact tgcttctaga caagagtccc 120
tctagaaatc ccttccagtc tatatgttac tggggccaag aattggtcac cggcgggaat 180
cttacattga gtaacgggca gctccgatca cagagatatt ggcacacctt gagttcgacg 240
cccatcctcc gaatctgtat gagatcctgc ttctccttac gttctccgaa actacagttg 300
cgtccgatac cagttttatg tttcttcatg ggagcgacca atatcagttt acgcttcgca 360
agccaaggga cggtggatat agttcatagt gttgaacgtt ccgagagtca gtcccgcacc 420
tacgtgtttt tggaactgtg ggccttcggg ttttacacag cctttggttt cagcatgcta 480
ttagtctcca ccttggaggc acacctaatc acggtaaagg gtgatggcct aatacgttgg 540
gatgtagcgc gctccttccg gtcaggtcac gaggatggag cgtgtcttac acgcgatccg 600
tgcggtccgc agtttgcgtc tgacgactac gagccgcgtt cttgcctacc ccagatgcta 660
tcggcgagag ggggtcccgg ttcgtttatc gttgtgtatg gttgtcattg ggctcaattg 720
cggattcagg cggggctagc aaaccaagtg ttgagtgttt gtcttatttg taaggcatat 780
atgatctcag agtttttgtc catacctaac cattcctatt acttgcgcgc gccatgtgaa 840
caaggtaaaa tgttgataga tgcgaggcac ctttggctac gggtagagcg gctgaattct 900
atcattgcag gtctggcatc acttcgtaag cgaggtaata ctcgcaccag cttgaactca 960
atccttttat ttagtaagga tcaacagtat aaaatgcggc gcgccgcact gagtatacta 1020
ctatattggg gctatttcac agtccgcgca tcctgcgata atcttgtggc cactctacgg 1080
aaagaccccc gggaatacga ttcggcgact gggccgtcga aactttgtca gcccaaagct 1140
catccctgtc atccgatgca aatgtacctg agggactggg caggcaaatt aagagcaacg 1200
aagcggccag acaggggcgc ccaacaagaa catgcggtga accccgccgg ctaccatcaa 1260
atgcagagtg caaggttggt tgcgccttta accccgtccg cccagcttac tgagcgtgat 1320
tgtacaggaa aggttgggct tgaccttcga cgtcagatgt ag 1362
<210> 2
<211> 453
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Met Arg Thr Arg His Ser Arg Thr Leu Leu Leu Glu His Leu Ala Thr
1 5 10 15
Glu Arg Arg Arg Leu Ala Pro Trp Asn Ile Gly Ser Ala Ser Thr Arg
20 25 30
His Leu Leu Leu Asp Lys Ser Pro Ser Arg Asn Pro Phe Gln Ser Ile
35 40 45
Cys Tyr Trp Gly Gln Glu Leu Val Thr Gly Gly Asn Leu Thr Leu Ser
50 55 60
Asn Gly Gln Leu Arg Ser Gln Arg Tyr Trp His Thr Leu Ser Ser Thr
65 70 75 80
Pro Ile Leu Arg Ile Cys Met Arg Ser Cys Phe Ser Leu Arg Ser Pro
85 90 95
Lys Leu Gln Leu Arg Pro Ile Pro Val Leu Cys Phe Phe Met Gly Ala
100 105 110
Thr Asn Ile Ser Leu Arg Phe Ala Ser Gln Gly Thr Val Asp Ile Val
115 120 125
His Ser Val Glu Arg Ser Glu Ser Gln Ser Arg Thr Tyr Val Phe Leu
130 135 140
Glu Leu Trp Ala Phe Gly Phe Tyr Thr Ala Phe Gly Phe Ser Met Leu
145 150 155 160
Leu Val Ser Thr Leu Glu Ala His Leu Ile Thr Val Lys Gly Asp Gly
165 170 175
Leu Ile Arg Trp Asp Val Ala Arg Ser Phe Arg Ser Gly His Glu Asp
180 185 190
Gly Ala Cys Leu Thr Arg Asp Pro Cys Gly Pro Gln Phe Ala Ser Asp
195 200 205
Asp Tyr Glu Pro Arg Ser Cys Leu Pro Gln Met Leu Ser Ala Arg Gly
210 215 220
Gly Pro Gly Ser Phe Ile Val Val Tyr Gly Cys His Trp Ala Gln Leu
225 230 235 240
Arg Ile Gln Ala Gly Leu Ala Asn Gln Val Leu Ser Val Cys Leu Ile
245 250 255
Cys Lys Ala Tyr Met Ile Ser Glu Phe Leu Ser Ile Pro Asn His Ser
260 265 270
Tyr Tyr Leu Arg Ala Pro Cys Glu Gln Gly Lys Met Leu Ile Asp Ala
275 280 285
Arg His Leu Trp Leu Arg Val Glu Arg Leu Asn Ser Ile Ile Ala Gly
290 295 300
Leu Ala Ser Leu Arg Lys Arg Gly Asn Thr Arg Thr Ser Leu Asn Ser
305 310 315 320
Ile Leu Leu Phe Ser Lys Asp Gln Gln Tyr Lys Met Arg Arg Ala Ala
325 330 335
Leu Ser Ile Leu Leu Tyr Trp Gly Tyr Phe Thr Val Arg Ala Ser Cys
340 345 350
Asp Asn Leu Val Ala Thr Leu Arg Lys Asp Pro Arg Glu Tyr Asp Ser
355 360 365
Ala Thr Gly Pro Ser Lys Leu Cys Gln Pro Lys Ala His Pro Cys His
370 375 380
Pro Met Gln Met Tyr Leu Arg Asp Trp Ala Gly Lys Leu Arg Ala Thr
385 390 395 400
Lys Arg Pro Asp Arg Gly Ala Gln Gln Glu His Ala Val Asn Pro Ala
405 410 415
Gly Tyr His Gln Met Gln Ser Ala Arg Leu Val Ala Pro Leu Thr Pro
420 425 430
Ser Ala Gln Leu Thr Glu Arg Asp Cys Thr Gly Lys Val Gly Leu Asp
435 440 445
Leu Arg Arg Gln Met
450
<210> 3
<211> 1359
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
atgcggacgc gccacagcag aactctgcta ctcgagcatc ttgccacaga aagacgacgt 60
ttagctccgt ggaacatagg gtccgcttca acaagacact tgcttctaga caagagtccc 120
tctagaaatc ccttccagtc tatatgttac tggggccaag aattggtcac cggcgggaat 180
cttacattga gtaacgggca gctccgatca cagagatatt ggcacacctt gagttcgacg 240
cccatcctcc gaatctgtat gagatcctgc ttctccttac gttctccgaa actacagttg 300
cgtccgatac cagttttatg tttcttcatg ggagcgagca acagtttacg cttcgcaagc 360
caagggacgg tggatatagt tcatagtgtt gaacgttccg agagtcagtc ccgcacctac 420
gtgtttttgg aactgtgggc cttcgggttt tacacagcct ttggtttcag catgctatta 480
gtctccacct tggaggcaca cctaatcacg gtaaagggtg atggcctaat acgttgggat 540
gtagcgcgct ccttccggtc aggtcacgag gatggagcgt gtcttacacg cgatccgtgc 600
ggtccgcagt ttgcgtctga cgactacgag ccgcgttctt gcctacccca gatgctatcg 660
gcgagagggg gtcccggttc gtttaccgat gtgtatggtt gtcattgggc tcaattgcgg 720
attcaggcgg ggctagcaaa ccaagtgttg agtgtttgtc ttatttgtaa ggcatatatg 780
atctcagagt ttttgtccat acctaaccat tcctattact tgcgcgcgcc atgtgaacaa 840
ggtaaaatgt tgatagatgc gaggcacctt tggctacggg tagagcggct gaattctatc 900
attgcaggtc tggcatcact tcgtaagcga ggtaatactc gcaccagctt gaactcaatc 960
cttttattta gtaaggatca acagtataaa atgcggcgcg ccgcactgag tatactacta 1020
tattggggct atttcacagt ccgcgcatcc tgcgataatc ttgtggccac tctacggaaa 1080
gacccccggg aatacgattc ggcgactggg ccgtcgaaac tttgtcagcc caaagctcat 1140
ccctgtcatc cgatgcaaat gtacctgagg gactgggcag gcaaattaag agcaacgaag 1200
cggccagaca ggggcgccca acaagaacat gcggtgaacc ccgccggcta ccatcaaatg 1260
cagagtgcaa ggttggttgc gcctttaacc ccgtccgccc agcttactga gcgtgattgt 1320
acaggaaagg ttgggcttga ccttcgacgt cagatgtag 1359
<210> 4
<211> 452
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 4
Met Arg Thr Arg His Ser Arg Thr Leu Leu Leu Glu His Leu Ala Thr
1 5 10 15
Glu Arg Arg Arg Leu Ala Pro Trp Asn Ile Gly Ser Ala Ser Thr Arg
20 25 30
His Leu Leu Leu Asp Lys Ser Pro Ser Arg Asn Pro Phe Gln Ser Ile
35 40 45
Cys Tyr Trp Gly Gln Glu Leu Val Thr Gly Gly Asn Leu Thr Leu Ser
50 55 60
Asn Gly Gln Leu Arg Ser Gln Arg Tyr Trp His Thr Leu Ser Ser Thr
65 70 75 80
Pro Ile Leu Arg Ile Cys Met Arg Ser Cys Phe Ser Leu Arg Ser Pro
85 90 95
Lys Leu Gln Leu Arg Pro Ile Pro Val Leu Cys Phe Phe Met Gly Ala
100 105 110
Ser Asn Ser Leu Arg Phe Ala Ser Gln Gly Thr Val Asp Ile Val His
115 120 125
Ser Val Glu Arg Ser Glu Ser Gln Ser Arg Thr Tyr Val Phe Leu Glu
130 135 140
Leu Trp Ala Phe Gly Phe Tyr Thr Ala Phe Gly Phe Ser Met Leu Leu
145 150 155 160
Val Ser Thr Leu Glu Ala His Leu Ile Thr Val Lys Gly Asp Gly Leu
165 170 175
Ile Arg Trp Asp Val Ala Arg Ser Phe Arg Ser Gly His Glu Asp Gly
180 185 190
Ala Cys Leu Thr Arg Asp Pro Cys Gly Pro Gln Phe Ala Ser Asp Asp
195 200 205
Tyr Glu Pro Arg Ser Cys Leu Pro Gln Met Leu Ser Ala Arg Gly Gly
210 215 220
Pro Gly Ser Phe Thr Asp Val Tyr Gly Cys His Trp Ala Gln Leu Arg
225 230 235 240
Ile Gln Ala Gly Leu Ala Asn Gln Val Leu Ser Val Cys Leu Ile Cys
245 250 255
Lys Ala Tyr Met Ile Ser Glu Phe Leu Ser Ile Pro Asn His Ser Tyr
260 265 270
Tyr Leu Arg Ala Pro Cys Glu Gln Gly Lys Met Leu Ile Asp Ala Arg
275 280 285
His Leu Trp Leu Arg Val Glu Arg Leu Asn Ser Ile Ile Ala Gly Leu
290 295 300
Ala Ser Leu Arg Lys Arg Gly Asn Thr Arg Thr Ser Leu Asn Ser Ile
305 310 315 320
Leu Leu Phe Ser Lys Asp Gln Gln Tyr Lys Met Arg Arg Ala Ala Leu
325 330 335
Ser Ile Leu Leu Tyr Trp Gly Tyr Phe Thr Val Arg Ala Ser Cys Asp
340 345 350
Asn Leu Val Ala Thr Leu Arg Lys Asp Pro Arg Glu Tyr Asp Ser Ala
355 360 365
Thr Gly Pro Ser Lys Leu Cys Gln Pro Lys Ala His Pro Cys His Pro
370 375 380
Met Gln Met Tyr Leu Arg Asp Trp Ala Gly Lys Leu Arg Ala Thr Lys
385 390 395 400
Arg Pro Asp Arg Gly Ala Gln Gln Glu His Ala Val Asn Pro Ala Gly
405 410 415
Tyr His Gln Met Gln Ser Ala Arg Leu Val Ala Pro Leu Thr Pro Ser
420 425 430
Ala Gln Leu Thr Glu Arg Asp Cys Thr Gly Lys Val Gly Leu Asp Leu
435 440 445
Arg Arg Gln Met
450
<210> 5
<211> 1365
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
atgcggacgc gccacagcag aactctgcta ctcgagcatc ttgccacaga aagacgacgt 60
ttagctccgt ggaacatagg gtccgcttca acaagacact tgcttctaga caagagtccc 120
tctagaaatc ccttccagtc tatatgttac tggggccaag aattggtcac cggcgggaat 180
cttacattga gtaacgggca gctccgatca cagagatatt ggcacacctt gagttcgacg 240
cccatcctcc gaatctgtat gagatcctgc ttctccttac gttctccgaa actacagttg 300
cgtccgatac cagttttatg tttcttcatg ggaccgagca aaagtttacg cttcgcaagc 360
caagggacgg tggatatagt tcatagtgtt gaacgttccg agagtcagtc ccgcacctac 420
gtgtttttgg aactgtgggc cttcgggttt tacacagcct ttggtttcag catgctatta 480
gtctccacct tggaggcaca cctaatcacg gtaaagggtg atggcctaat acgttgggat 540
gtagcgcgct ccttccggtc aggtcacgag gatggagcgt gtcttacacg cgatccgtgc 600
ggtccgcagt ttgcgtctga cgactacgag ccgcgttctt gcctacccca gatgctatcg 660
gcgagagggg gtcccgtttc gtttaccgat gtgtatggtt gtcattgggc tcaattgcgg 720
attcaggcgg ggctagcaaa ccaagtgttg agtgtttgtc ttatttgtaa ggcatatatg 780
atctcagagt ttttgtccat acctaaccat tcctattact tgcgcgcgcc atgtgaacaa 840
ggtaaaatgt tgatagatgc gaggcacctt tggctacggg tagagcggct gaattctatc 900
attgcaggtc tggcatcact tcgtaagcga ggtaatactc gcaccagctt gaactcaatc 960
cttttattta gtaaggatca acagtataaa atgcggcgcg ccgcactgag tatactacta 1020
tattggggct atttcacagt ccgcgcatcc tgcgataatc ttgtggccac tctacggaaa 1080
gacccccggg aatacgattc ggcgactggg ccgtcgaaac tttgtcagcc caaagctcat 1140
ccctgtcatc cgatgcaaat gtacctgagg gactgggcag gcaaattaag agcaacgaag 1200
cggccagaca ggggcgccca acaagaacat gcggtgaacc ccgccggcta ccatcaaatg 1260
cagagtgcaa ggttggttgc gcctttaacc ccgtccgccc agcttactga gcgcagccac 1320
gattgtacag gaaaggttgg gcttgacctt cgacgtcaga tgtag 1365
<210> 6
<211> 454
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 6
Met Arg Thr Arg His Ser Arg Thr Leu Leu Leu Glu His Leu Ala Thr
1 5 10 15
Glu Arg Arg Arg Leu Ala Pro Trp Asn Ile Gly Ser Ala Ser Thr Arg
20 25 30
His Leu Leu Leu Asp Lys Ser Pro Ser Arg Asn Pro Phe Gln Ser Ile
35 40 45
Cys Tyr Trp Gly Gln Glu Leu Val Thr Gly Gly Asn Leu Thr Leu Ser
50 55 60
Asn Gly Gln Leu Arg Ser Gln Arg Tyr Trp His Thr Leu Ser Ser Thr
65 70 75 80
Pro Ile Leu Arg Ile Cys Met Arg Ser Cys Phe Ser Leu Arg Ser Pro
85 90 95
Lys Leu Gln Leu Arg Pro Ile Pro Val Leu Cys Phe Phe Met Gly Pro
100 105 110
Ser Lys Ser Leu Arg Phe Ala Ser Gln Gly Thr Val Asp Ile Val His
115 120 125
Ser Val Glu Arg Ser Glu Ser Gln Ser Arg Thr Tyr Val Phe Leu Glu
130 135 140
Leu Trp Ala Phe Gly Phe Tyr Thr Ala Phe Gly Phe Ser Met Leu Leu
145 150 155 160
Val Ser Thr Leu Glu Ala His Leu Ile Thr Val Lys Gly Asp Gly Leu
165 170 175
Ile Arg Trp Asp Val Ala Arg Ser Phe Arg Ser Gly His Glu Asp Gly
180 185 190
Ala Cys Leu Thr Arg Asp Pro Cys Gly Pro Gln Phe Ala Ser Asp Asp
195 200 205
Tyr Glu Pro Arg Ser Cys Leu Pro Gln Met Leu Ser Ala Arg Gly Gly
210 215 220
Pro Val Ser Phe Thr Asp Val Tyr Gly Cys His Trp Ala Gln Leu Arg
225 230 235 240
Ile Gln Ala Gly Leu Ala Asn Gln Val Leu Ser Val Cys Leu Ile Cys
245 250 255
Lys Ala Tyr Met Ile Ser Glu Phe Leu Ser Ile Pro Asn His Ser Tyr
260 265 270
Tyr Leu Arg Ala Pro Cys Glu Gln Gly Lys Met Leu Ile Asp Ala Arg
275 280 285
His Leu Trp Leu Arg Val Glu Arg Leu Asn Ser Ile Ile Ala Gly Leu
290 295 300
Ala Ser Leu Arg Lys Arg Gly Asn Thr Arg Thr Ser Leu Asn Ser Ile
305 310 315 320
Leu Leu Phe Ser Lys Asp Gln Gln Tyr Lys Met Arg Arg Ala Ala Leu
325 330 335
Ser Ile Leu Leu Tyr Trp Gly Tyr Phe Thr Val Arg Ala Ser Cys Asp
340 345 350
Asn Leu Val Ala Thr Leu Arg Lys Asp Pro Arg Glu Tyr Asp Ser Ala
355 360 365
Thr Gly Pro Ser Lys Leu Cys Gln Pro Lys Ala His Pro Cys His Pro
370 375 380
Met Gln Met Tyr Leu Arg Asp Trp Ala Gly Lys Leu Arg Ala Thr Lys
385 390 395 400
Arg Pro Asp Arg Gly Ala Gln Gln Glu His Ala Val Asn Pro Ala Gly
405 410 415
Tyr His Gln Met Gln Ser Ala Arg Leu Val Ala Pro Leu Thr Pro Ser
420 425 430
Ala Gln Leu Thr Glu Arg Ser His Asp Cys Thr Gly Lys Val Gly Leu
435 440 445
Asp Leu Arg Arg Gln Met
450
<210> 7
<211> 1365
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
atgcggacgc gccacagcag aactctgcta ctcgagcatc ttgccacaga aagacgacgt 60
ttagctccgt ggaacatagg gtccgcttca acaagacact tgcttctaga caagagtccc 120
tctagaaatc ccttccagtc tatatgttac tggggccaag aattggtcac cggcgggaat 180
cttacattga gtaacgggca gctccgatca cagagatatt ggcacacctt gagttcgacg 240
cccatcctcc gaatctgtat gagatcctgc ttctccttac gttctccgaa actacagttg 300
cgtccgatac cagttttatg tttcttcatg ggaccgagca gaagtttacg cttcgcaagc 360
caagggacgg tggatatagt tcatagtgtt gaacgttccg agagtcagtc ccgcacctac 420
gtgtttttgg aactgtgggc cttcgggttt tacacagcct ttggtttcag catgctatta 480
gtctccacct tggaggcaca cctaatcacg gtaaagggtg atggcctaat acgttgggat 540
gtagcgcgct ccttccggtc aggtcacgag gatggagcgt gtcttacacg cgatccgtgc 600
ggtccgcagt ttgcgtctga cgactacgag ccgcgttctt gcctacccca gatgctatcg 660
gcgagagggg gtcccgtttt taccgatctt tatatgtgtc attgggctca attgcggatt 720
caggcggggc tagcaaacca agtgttgagt gtttgtctta tttgtaaggc atatatgatc 780
tcagagtttt tgtccatacc taaccattcc tattacttgc gcgcgccatg tgaacaaggt 840
aaaatgttga tagatgcgag gcacctttgg ctacgggtag agcggctgaa ttctatcatt 900
gcaggtctgg catcacttcg taagcgaggt aatactcgca ccagcttgaa ctcaatcctt 960
ttatttagta aggatcaaca gtataaaatg cggcgcgccg cactgagtat actactatat 1020
tggggctatt tcacagtccg cgcatcctgc gataatcttg tggccactct acggaaagac 1080
ccccgggaat acgattcggc gactgggccg tcgaaacttt gtcagcccaa agctcatccc 1140
tgtcatccga tgcaaatgta cctgagggac tgggcaggca aattaagagc aacgaagcgg 1200
ccagacaggg gcgcccaaca agaacatgcg gtgaaccccg ccggctacca tcaaatgcag 1260
agtgcaaggt tggttgcgcc tttaaccccg tccgcccagc ttactgagcg cagccacaca 1320
gattgtacag gaaaggttgg gcttgacctt cgacgtcaga tgtag 1365
<210> 8
<211> 454
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 8
Met Arg Thr Arg His Ser Arg Thr Leu Leu Leu Glu His Leu Ala Thr
1 5 10 15
Glu Arg Arg Arg Leu Ala Pro Trp Asn Ile Gly Ser Ala Ser Thr Arg
20 25 30
His Leu Leu Leu Asp Lys Ser Pro Ser Arg Asn Pro Phe Gln Ser Ile
35 40 45
Cys Tyr Trp Gly Gln Glu Leu Val Thr Gly Gly Asn Leu Thr Leu Ser
50 55 60
Asn Gly Gln Leu Arg Ser Gln Arg Tyr Trp His Thr Leu Ser Ser Thr
65 70 75 80
Pro Ile Leu Arg Ile Cys Met Arg Ser Cys Phe Ser Leu Arg Ser Pro
85 90 95
Lys Leu Gln Leu Arg Pro Ile Pro Val Leu Cys Phe Phe Met Gly Pro
100 105 110
Ser Arg Ser Leu Arg Phe Ala Ser Gln Gly Thr Val Asp Ile Val His
115 120 125
Ser Val Glu Arg Ser Glu Ser Gln Ser Arg Thr Tyr Val Phe Leu Glu
130 135 140
Leu Trp Ala Phe Gly Phe Tyr Thr Ala Phe Gly Phe Ser Met Leu Leu
145 150 155 160
Val Ser Thr Leu Glu Ala His Leu Ile Thr Val Lys Gly Asp Gly Leu
165 170 175
Ile Arg Trp Asp Val Ala Arg Ser Phe Arg Ser Gly His Glu Asp Gly
180 185 190
Ala Cys Leu Thr Arg Asp Pro Cys Gly Pro Gln Phe Ala Ser Asp Asp
195 200 205
Tyr Glu Pro Arg Ser Cys Leu Pro Gln Met Leu Ser Ala Arg Gly Gly
210 215 220
Pro Val Phe Thr Asp Leu Tyr Met Cys His Trp Ala Gln Leu Arg Ile
225 230 235 240
Gln Ala Gly Leu Ala Asn Gln Val Leu Ser Val Cys Leu Ile Cys Lys
245 250 255
Ala Tyr Met Ile Ser Glu Phe Leu Ser Ile Pro Asn His Ser Tyr Tyr
260 265 270
Leu Arg Ala Pro Cys Glu Gln Gly Lys Met Leu Ile Asp Ala Arg His
275 280 285
Leu Trp Leu Arg Val Glu Arg Leu Asn Ser Ile Ile Ala Gly Leu Ala
290 295 300
Ser Leu Arg Lys Arg Gly Asn Thr Arg Thr Ser Leu Asn Ser Ile Leu
305 310 315 320
Leu Phe Ser Lys Asp Gln Gln Tyr Lys Met Arg Arg Ala Ala Leu Ser
325 330 335
Ile Leu Leu Tyr Trp Gly Tyr Phe Thr Val Arg Ala Ser Cys Asp Asn
340 345 350
Leu Val Ala Thr Leu Arg Lys Asp Pro Arg Glu Tyr Asp Ser Ala Thr
355 360 365
Gly Pro Ser Lys Leu Cys Gln Pro Lys Ala His Pro Cys His Pro Met
370 375 380
Gln Met Tyr Leu Arg Asp Trp Ala Gly Lys Leu Arg Ala Thr Lys Arg
385 390 395 400
Pro Asp Arg Gly Ala Gln Gln Glu His Ala Val Asn Pro Ala Gly Tyr
405 410 415
His Gln Met Gln Ser Ala Arg Leu Val Ala Pro Leu Thr Pro Ser Ala
420 425 430
Gln Leu Thr Glu Arg Ser His Thr Asp Cys Thr Gly Lys Val Gly Leu
435 440 445
Asp Leu Arg Arg Gln Met
450
<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 9
Met Ala Asn Cys Glu His Leu
1 5
<210> 10
<211> 24
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
atggccaact gtgaacatct gtga 24
<210> 11
<211> 9
<212> RNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
gaauguggu 9
<210> 12
<211> 63
<212> RNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
ggcauugugg aacaaugcug uaccagcauc ugcucccucu accagcugga gaacuacugc 60
aac 63
<210> 13
<211> 90
<212> RNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
uuugugaacc aacaccugug cggcucacac cugguggaag cucucuaccu agugugcggg 60
gaacgaggcu ucuucuacac acccaagacc 90
<210> 14
<211> 3
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 14
Glu Cys Gly
1
<210> 15
<211> 21
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 15
Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu
1 5 10 15
Glu Asn Tyr Cys Asn
20
<210> 16
<211> 30
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 16
Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr
1 5 10 15
Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr
20 25 30
<210> 17
<211> 9
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 17
gaatgtggt 9
<210> 18
<211> 63
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 18
ggcattgtgg aacaatgctg taccagcatc tgctccctct accagctgga gaactactgc 60
aac 63
<210> 19
<211> 90
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 19
tttgtgaacc aacacctgtg cggctcacac ctggtggaag ctctctacct agtgtgcggg 60
gaacgaggct tcttctacac acccaagacc 90

Claims (1)

1. A single-stranded RNA peptide ligase sRPlaseI characterized in that the amino acid sequence of the sRPlaseI ligase is as set forth in SEQ NO: 2, respectively.
CN202010077332.5A 2020-01-27 2020-01-27 Single-stranded RNA peptide ligase sRPoseI and use method thereof Expired - Fee Related CN111088236B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010077332.5A CN111088236B (en) 2020-01-27 2020-01-27 Single-stranded RNA peptide ligase sRPoseI and use method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010077332.5A CN111088236B (en) 2020-01-27 2020-01-27 Single-stranded RNA peptide ligase sRPoseI and use method thereof

Publications (2)

Publication Number Publication Date
CN111088236A CN111088236A (en) 2020-05-01
CN111088236B true CN111088236B (en) 2022-07-22

Family

ID=70399814

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010077332.5A Expired - Fee Related CN111088236B (en) 2020-01-27 2020-01-27 Single-stranded RNA peptide ligase sRPoseI and use method thereof

Country Status (1)

Country Link
CN (1) CN111088236B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587044A (en) * 1983-09-01 1986-05-06 The Johns Hopkins University Linkage of proteins to nucleic acids
CN110452303A (en) * 2019-08-08 2019-11-15 中国科学院武汉病毒研究所 It is covalently attached the method and application of nucleic acid and peptide or protein
CN110637086A (en) * 2017-03-17 2019-12-31 珂璧斯塔斯株式会社 Method for producing complex of RNA molecule and peptide, and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587044A (en) * 1983-09-01 1986-05-06 The Johns Hopkins University Linkage of proteins to nucleic acids
CN110637086A (en) * 2017-03-17 2019-12-31 珂璧斯塔斯株式会社 Method for producing complex of RNA molecule and peptide, and use thereof
CN110452303A (en) * 2019-08-08 2019-11-15 中国科学院武汉病毒研究所 It is covalently attached the method and application of nucleic acid and peptide or protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RNA-peptide fusions for the in vitro selection of peptides and proteins;Roberts, RW等;《PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA》;19971111;第94卷(第23期);第12297-12302页 *
Synthesis of a peptide-universal nucleotide antigen: towards next-generation antibodies to detect topoisomerase I-DNA covalent complexes;Perkins, AL等;《ORGANIC & BIOMOLECULAR CHEMISTRY》;20160413;第14卷(第17期);第4103-4109页 *

Also Published As

Publication number Publication date
CN111088236A (en) 2020-05-01

Similar Documents

Publication Publication Date Title
US8034910B2 (en) SUMO fusion protein expression system for producing native proteins
US10883091B2 (en) DNA polymerase variant and application thereof
EP1546313B1 (en) Thermostable rna ligase from thermus phage
CN110914415A (en) Engineered ligase variants
CN108779442A (en) Composition, system and the method for a variety of ligases
WO2022227880A1 (en) Novel phosphorylated adenylase, and preparation method therefor and application thereof
WO2019128836A1 (en) Improved promoter and use thereof
CN113785053A (en) Reverse transcriptase having improved enzymatic activity and use thereof
JP2022522397A (en) How to Regularly Build Circular and Linear DNA Molecules
CN111088236B (en) Single-stranded RNA peptide ligase sRPoseI and use method thereof
CN111088234B (en) Double-stranded DNA peptide ligase dDPlaseII and use method thereof
CN111117978B (en) Single-chain DNA peptide ligase sDPlaseI and use method thereof
CN111088235B (en) Double-stranded DNA peptide ligase dDPlaseI and use method thereof
WO2023273366A1 (en) Nucleic acid ligase
CN112725331B (en) Construction method of high-throughput mutant library
CN113930405B (en) Novel thermostable phosphorylation and adenylylation one-step catalytic enzyme, and preparation method and application thereof
CN115261363B (en) Method for measuring RNA deaminase activity of APOBEC3A and RNA high-activity APOBEC3A variant
KR100774102B1 (en) Thermostable dna ligase of sulfophobococcus zilligii
KR100673836B1 (en) Thermostable dna ligase of staphylothermus marinus
KR100861585B1 (en) Thermostable Pyrophosphatase from Picrophilus torridus
RU2300566C2 (en) RECOMBINANT PLASMID pSVH0106 PROVIDING SYNTHESIS OF Gl7ACA ACYLASE IN Escherichia coli CELLS, RECOMBINANT STRAIN OF Escherichia coli BL21(DE3)/pSVH0106 AS PRODUCER OF Gl7ACA ACYLASE
CN115011578A (en) Enhanced M-MLV reverse transcriptase mutant and application thereof
CN114875000A (en) Method for in vitro recombination of multi-subunit SCF E3 ligase by using fusion protein and application
CN116606834A (en) Multiple primordial enzymes with cleavage ligation activity and uses thereof
CN114230644A (en) GP32 protein mutant, recombinant vector, and construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20220706

Address after: 362300 room 114, building 5, yangguangyoujia, Meilin street, Nan'an City, Quanzhou City, Fujian Province

Applicant after: Huang Zhongshan

Address before: 350005 No. 178 on the east side of the second floor of the complex building, Lianpan 34, Xiangyuan street, Jin'an District, Fuzhou City, Fujian Province

Applicant before: Fujian chenxinke Biotechnology Co.,Ltd.

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220722